Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats (2023)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CAIRASCO, NORBERTO GARCIA - FMRP ; PANISSI, CHRISTIE RAMOS ANDRADE LEITE - FFCLRP
- Unidades: FMRP; FFCLRP
- DOI: 10.1016/j.bbr.2023.114588
- Subjects: CANNABIS; DOR CRÔNICA; DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO; FARMACOTERAPIA
- Keywords: Cannabidiol; Chronic pain; Conditioned place preference; FosB protein; GFAP; IBA-1
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Behavioural Brain Research
- ISSN: 0166-4328
- Volume/Número/Paginação/Ano: v. 452, art. 114588, p. 1-16, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, v. 452, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114588. Acesso em: 26 jan. 2025. -
APA
Cardoso, G. K. R. da S., Lopes, W. L., Primini, E. O., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., et al. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, 452, 1-16. doi:10.1016/j.bbr.2023.114588 -
NLM
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 jan. 26 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588 -
Vancouver
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 jan. 26 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588 - Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
Informações sobre o DOI: 10.1016/j.bbr.2023.114588 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003199791.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
